The comparative pharmacology of WG253 (rimiterol hydrobromide), a new bronchodilator.
D000336:Aerosols; D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D001986:Bronchial Spasm / Q000517:prevention & control; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002415:Cats; D003250:Constriction; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009921:Metaproterenol / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010047:Ovalbumin; D012702:Serotonin Antagonists; D014132:Trachea / Q000187:drug effects
D000336:Aerosols; D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D009921:Metaproterenol; D010047:Ovalbumin; D007545:Isoproterenol